Spontaneous clearance of chronic hepatitis C infection in a patient with a 20-year-old HIV-hepatitis C co-infection and chronic active hepatitis

International Journal of STD and AIDS

Volumn 23, Issue 3, 2012, Pages

  Manfredi, R ^a   Dentale, N ^a   Calza, L ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antiretroviral therapy; HCV HIV co infection; Hepatitis C; HIV; Protease inhibitors; Spontaneous HCV clearance

Indexed keywords

AMINOTRANSFERASE; DIDANOSINE; EFAVIRENZ; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; FOSAMPRENAVIR PLUS RITONAVIR; INDINAVIR; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ADULT; CASE REPORT; CD4 LYMPHOCYTE COUNT; DISEASE COURSE; DRUG DEPENDENCE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATTY LIVER; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEPATITIS C; HEPATOMEGALY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTRIGLYCERIDEMIA; IMMUNOLOGICAL PARAMETERS; MALE; MIXED INFECTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SPLENOMEGALY; TREATMENT RESPONSE; VIRAL CLEARANCE; VIRUS LOAD;

COINFECTION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HEPATITIS, CHRONIC; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; VIRAL LOAD;

EID: 84860910573     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2009.009333     Document Type: Review

References (19)

1. Cooper CL, Cameron DW. Review of the effect of highly active antiretroviral therapy on hepatitis C virus (HCV) RNA levels in human immunodeficiency virus and HCV coinfection. Clin Infect Dis 2002;35:873-9
2. Rutschmann OT, Negro F, Hirschel B, Hadengue A, Anwar D, Perrin LH. Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV. J Infect Dis 1998;177:783-5
3. Koziel MJ, Peters MG. Viral hepatitis in HIV infection. New Engl J Med 2007;356:1445-54
4. Manfredi R. Coinfection with HIV and hepatitis C virus and immune restoration. Clin Infect Dis 2006;42:298-9
5. Franchini M, Mengoli C, Veneri D, Mazzi R, Lippi G, Cruciani M. Treatment of chronic hepatitis C in haemophilic patients with interferon and ribavirin. A meta-analysis. J Antimicrob Chemother 2008;61:1191-200.
6. Fialaire P, Payan C, Vitour D, et al. Sustained disappearance of hepatitis C viremia in patients receiving protease inhibitor treatment for human immunodeficiency virus infection. J Infect Dis 1999;180:574-5
7. Weissbrich B, Langmann P, Schubert J, Jassoy C, Klinker H. Resolution of HCV infection in a HIV-infected patient under HAART after several hepatitis flare-ups. Eur J Med Res 2003;8:495-8
8. Torti C, Barnes E, Quiros-Roldan E, Puoti M, Carosi G, Klenerman P. Suppression of hepatitis C virus replication is maintained long term following HAART therapy, in an individual with HCV/HIV co-infection. Antivir Ther 2004;9:139-42
9. Zietoun JD, Mallet V, Chaix ML, Viard JP, Blanche S, Pol S. Stable recovery from HCV in HIV-HCV co-infection under antiretroviral therapy. J Clin Virol 2007;40:71-3
10. De Rosa FG, Audagnotto S, Bargiacchi O, et al. Resolution of HCV infection after highly active antiretroviral therapy in a HIV-HCV coinfected patient. J Infect 2006;53:e215-8
11. Falconer L, Gonzalez VD, Reichard O, Sandberg JK, Alaeus A. Spontaneous HCV clearance in HCV/HIV-1 coinfection associated with normalized CD4 counts, low level of chronic immune activation and high level of T cell function. J Clin Virol 2008;41:160-3
12. Endo T, Fujimoto K, Nishio M, et al. Case report: clearance of hepatitis C virus after changing the HAART regimen in a patient infected with hepatitis C virus and the human immunodeficiency virus. J Med Virol 2009;81:979-82
13. Martín-Carbonero L, Barreiro P, Jiménez-Galán G, et al. Clearance of hepatitis C virus in HIV-infected patients with multiple chronic viral hepatitis. J Viral Hepat 2007;14:392-5
14. Maida I, Ríos MJ, Pérez-Saleme L, et al. Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era. AIDS Res Hum Retroviruses 2008;24:679-83
15. Matsiota-Bernard P, Vrioni G, Onody C, Bernard L, De Truchis P, Peronne C. Human immunodeficiency virus (HIV) protease inhibitors have no effect on hepatitis C (HCV) serum levels of HIV-HCV co-infected patients. Int J Antimicrob Agents 2001;17:155-7
16. Liu-Young G, Kozal MJ. Hepatitis C protease and polymerase inhibitors in development. AIDS Patient Care STDs 2008;22:449-57
17. Tsantrizos YS. Peptidomimetic therapeutic agents targeting the protease enzyme of the human immunodeficiency virus and hepatitis C virus. Acc Chem Res 2008;41:1252-63
18. Seminari E, De Bona A, Gentilini G, et al. Amprenavir and ritonavir plasma concentrations in HIV-infected patients treated with fosamprenavir/ritonavir with various degrees of liver impairment. J Antimicrob Chemother 2007;60:831-6
19. Gatti F, Nasta P, Loregian A, et al. Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis. J Antimicrob Chemother 2009;63:575-8